Biblio

Found 145 results
[ Author(Desc)] Keyword Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Barral S, Reitz C, Small SA, Mayeux R.  2014.  Genetic variants in a 'cAMP element binding protein' (CREB)-dependent histone acetylation pathway influence memory performance in cognitively healthy elderly individuals.. Neurobiol Aging. 35(12):2881.e7-2881.e10.
Barral S, Cosentino S, Costa R, Andersen SL, Christensen K, Eckfeldt JH, Newman AB, Perls TT, Province MA, Hadley EC et al..  2013.  Exceptional memory performance in the Long Life Family Study.. Neurobiol Aging. 34(11):2445-8.
Beecham GW, Bis JC, Martin ER, Choi S-H, Destefano AL, van Duijn CM, Fornage M, Gabriel SB, Koboldt DC, Larson DE et al..  2017.  The Alzheimer's Disease Sequencing Project: Study design and sample selection.. Neurol Genet. 3(5):e194.
Beecham GW, Martin ER, Li Y-J, Slifer MA, Gilbert JR, Haines JL, Pericak-Vance MA.  2009.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.. Am J Hum Genet. 84(1):35-43.
Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel J-P, Younkin SG et al..  2014.  Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.. PLoS Genet. 10(9):e1004606.
Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS.  2012.  Overview and findings from the religious orders study.. Curr Alzheimer Res. 9(6):628-45.
Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS.  2012.  Overview and findings from the rush Memory and Aging Project.. Curr Alzheimer Res. 9(6):646-63.
Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BMM, Hooli B, Divito J, Ionita I et al..  2008.  Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.. Am J Hum Genet. 83(5):623-32.
Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, Salerno WJ, Lancour D, Ma Y, Renton AE et al..  2018.  Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.. Mol Psychiatry.
Blue EE, Bis JC, Dorschner MO, Tsuang DW, Barral SM, Beecham G, Below JE, Bush WS, Butkiewicz M, Cruchaga C et al..  2018.  Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.. Dement Geriatr Cogn Disord. 45(1-2):1-17.
Boyles AL, Scott WK, Martin ER, Schmidt S, Li Y-J, Ashley-Koch A, Bass MP, Schmidt M, Pericak-Vance MA, Speer MC et al..  2005.  Linkage disequilibrium inflates type I error rates in multipoint linkage analysis when parental genotypes are missing.. Hum Hered. 59(4):220-7.
Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CHong, Kouri N, Ross OA, Höglinger GU, Müller U et al..  2018.  Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.. PLoS Med. 15(1):e1002487.
Busby V, Goossens S, Nowotny P, Hamilton G, Smemo S, Harold D, Turic D, Jehu L, Myers A, Womick M et al..  2004.  Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.. Neuromolecular Med. 5(2):133-46.
Butkiewicz M, Blue EE, Leung YYee, Jian X, Marcora E, Renton AE, Kuzma A, San Wang L-, Koboldt DC, Haines JL et al..  2018.  Functional annotation of genomic variants in studies of late-onset Alzheimer's disease.. Bioinformatics. 34(16):2724-2731.
C
Carrasquillo MM, Zou F, V Pankratz S, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS, Younkin LH, Bisceglio GD et al..  2009.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.. Nat Genet. 41(2):192-8.
Chen JA, Wang Q, Davis-Turak J, Li Y, Karydas AM, Hsu SC, Sears RL, Chatzopoulou D, Huang AY, Wojta KJ et al..  2015.  A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.. JAMA Neurol. 72(4):414-22.
Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K et al..  2010.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. Hum Mol Genet. 19(16):3295-301.
Crane PK, Foroud T, Montine TJ, Larson EB.  2017.  Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.. Alzheimers Dement. 13(12):1410-1413.
Cruchaga C, Karch CM, Jin SChih, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S et al..  2014.  Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.. Nature. 505(7484):550-554.
Cruchaga C, Kauwe JSK, Harari O, Jin SChih, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D et al..  2013.  GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.. Neuron. 78(2):256-68.
Curtis D, Bakaya K, Sharma L, Bandyopadhyay S.  2020.  Weighted burden analysis of exome-sequenced late-onset Alzheimer's cases and controls provides further evidence for a role for PSEN1 and suggests involvement of the PI3K/Akt/GSK-3β and WNT signalling pathways.. Ann Hum Genet. 84(3):291-302.